publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
abstractmultipl
sclerosi
chronic
diseas
begin
late
adolesc
adulthood
highli
variabl
express
sever
believ
autoimmun
natur
caus
unknown
genet
environment
factor
implic
pathogenesi
ms
gener
present
acut
subacut
onset
neurolog
abnorm
may
wax
wane
mani
year
diagnosi
gener
made
mean
observ
clinic
cours
conjunct
neurolog
examin
laboratori
test
test
may
includ
magnet
reson
imag
head
spine
lumbar
punctur
evok
potenti
treatment
base
gener
suppor
ive
care
use
corticosteroid
relaps
symptomat
manag
ongo
problem
frequenc
relaps
reduc
betaseron
copolym
la
evalu
us
food
drug
administr
approv
use
reduct
frequenc
relaps
relapsingremit
ms
treatment
chronic
progress
often
attempt
immunosuppress
agent
corticosteroid
azathioprin
cyclophosphamid
use
agent
investig
multipl
sclerosi
ms
chronic
diseas
central
nervou
system
typic
begin
late
adolesc
earli
adulthood
caus
unknown
although
diseas
believ
autoimmun
natur
genet
environment
factor
implic
pathogenesi
ms
viral
caus
postul
singl
viru
confirm
associ
ms
patholog
featur
ms
includ
presenc
demyelin
area
white
matter
brain
perivascular
inflamm
rel
spare
axon
plaqu
commonli
found
periventricular
area
cerebr
hemispher
optic
nerv
brainstem
cerebellum
spinal
cord
presenc
inflamm
ms
plaqu
presenc
oligoclon
immunoglobulin
band
suggest
autoimmun
basi
diseas
character
inflammatori
cell
plaqu
cerebrospin
fluid
reveal
predomin
cell
find
focus
great
deal
attent
trimolecular
complex
consist
major
histocompat
complex
tcell
receptor
antigen
consist
associ
haplotyp
identifi
white
person
studi
restrict
use
specif
tcell
receptor
region
immun
process
reveal
specif
receptor
diseas
antigen
remain
unknown
although
mani
investig
work
myelin
basic
protein
protein
associ
myelin
two
anim
model
experiment
allerg
encephalomyel
theiler
murin
encephalomyel
valuabl
test
experiment
immunotherapi
aspect
autoimmun
mediat
demyelin
ms
gener
appear
acut
subacut
onset
neurolog
abnorm
may
wax
wane
mani
year
common
earli
symptom
includ
numb
doubl
vision
paraparesi
monoparesi
bladder
control
problem
optic
neuriti
ataxia
tremor
common
ongo
symptom
includ
mention
vertigo
increas
spastic
depress
emot
labil
gait
abnorm
fatigu
dysarthria
quadriparesi
constip
incoordin
fatigu
pain
diagnosi
made
mean
observ
clinic
cours
conjunct
neurolog
examin
laboratori
test
magnet
reson
imag
head
spine
valuabl
evalu
suspect
ms
presenc
elev
immunoglobulin
g
igg
index
oligoclon
band
spinal
fluid
also
help
evok
potenti
help
confirm
subclin
involv
eye
vestibular
function
sensori
tract
differenti
diagnosi
ms
includ
demyelin
syndrom
particularli
monophas
syndrom
postinfecti
encephalomyel
postinfecti
transvers
myeliti
isol
optic
neuriti
infecti
diseas
lyme
diseas
syphili
myelopathi
confus
ms
autoimmun
condit
system
lupu
erythematosu
behcet
syndrom
sarcoidosi
sjogren
syndrom
caus
symptom
similar
ms
leukodystrophi
hereditari
degen
syndrom
confus
ms
ms
often
classifi
clinic
cours
benign
ms
characdm
januari
teriz
mild
intermitt
relaps
nearli
complet
resolut
relapsingremit
ms
common
form
diseas
character
episod
acut
subacut
neurolog
dysfunct
follow
period
improv
stabil
secondari
progress
ms
begin
relapsingremit
cours
diseas
gradual
worsen
caus
slow
accumul
neurolog
sign
symptom
ms
never
relapsingremit
cours
begin
slow
progress
sign
symptom
classifi
primari
progress
ms
treatment
ms
base
progress
individu
case
gener
health
measur
includ
exercis
physic
occup
therapi
balanc
diet
aggress
treatment
fever
overh
treatment
relaps
recommend
moder
sever
relaps
corticosteroid
choic
treatment
relaps
steroid
use
caution
larg
number
side
effect
associ
longterm
use
frequenc
relaps
reduc
betaseron
copolym
evalu
us
food
drug
administr
approv
use
reduct
frequenc
relaps
relapsingremit
ms
drug
soon
may
avail
clinic
use
treatment
chronic
progress
often
attempt
immunosuppress
agent
corticosteroid
azathioprin
methotrex
cyclophosphamid
cytoxan
agent
investig
cladribin
intraven
immunoglobulin
symptomat
treatment
chronic
symptom
ms
import
treatment
symptom
help
patient
remain
function
comfort
even
rel
sever
chronic
problem
fatigu
treat
rest
break
day
exercis
energyconserv
techniqu
medic
may
help
amantadin
hydrochlorid
pemolin
spastic
sever
problem
caus
contractur
pain
insomnia
increas
fatigu
treat
conserv
physic
therapi
particularli
stretch
exercis
baclofen
diazepam
also
use
often
use
alon
combin
patient
sever
spastic
baclofen
administ
intrathec
pump
urinari
dysfunct
common
problem
urologist
usual
need
defin
type
dysfunct
present
hyperton
spastic
bladder
treat
anticholinerg
agent
hypoton
bladder
may
requir
intermitt
longterm
catheter
detrusorsphinct
dyssynergia
may
requir
combin
anticholinerg
agent
intermitt
catheter
urinari
retent
caus
frequent
bladder
infect
may
requir
acidif
urin
longterm
administr
antibiot
patient
sever
retent
may
requir
urinari
divers
sexual
dysfunct
often
requir
multidisciplinari
approach
includ
counsel
modif
sexual
techniqu
medic
prosthet
devic
men
tremor
sever
intract
problem
medic
includ
clonazepam
propranolol
acetazolamid
diazepam
emot
problem
common
patient
ms
emot
labil
may
respond
tricycl
antidepress
medic
depress
treat
antidepress
agent
counsel
pain
promin
concern
mani
patient
ms
dysesthet
pain
often
manag
tricycl
antidepress
carbamazepin
phenytoin
dilantin
valproic
acid
musculoskelet
pain
treat
antiinflammatori
medic
physic
therapi
cognit
dysfunct
disabl
distress
compon
ms
document
neuropsychiatr
test
may
help
manag
problem
current
investig
ms
center
concept
autoimmun
possibl
mediat
viral
ill
studi
design
defin
role
immun
system
ms
may
use
medic
design
reduc
specif
autoimmun
respons
medic
assist
stimul
remyelin
improv
qualiti
life
develop
past
year
great
stride
made
understand
role
immun
system
improv
diagnost
capabl
manag
problem
associ
ms
trend
continu
may
divers
effect
therapi
manag
ms
tabl
jean
martin
charcot
descript
clinic
patholog
featur
ms
foundat
knowledg
diseasel
histor
aspect
ms
review
previou
public
enter
new
phase
understand
brought
care
clinic
trial
capabl
monitor
disord
longitudin
magnet
reson
imag
mri
individu
patient
ms
describ
mean
clinic
observ
current
concept
clinic
cours
rel
frequenc
mri
characterist
ms
portray
tabl
investig
mri
chang
concept
ms
demonstr
evid
diseas
activ
expect
clinic
examin
diseas
activ
measur
mri
particularli
high
among
patient
chronic
progress
diseas
acut
lesion
ms
demonstr
gadoliniumenhanc
mri
initi
event
associ
local
disrupt
bloodbrain
barrier
fig
abnorm
evolv
increas
signal
intens
becom
evid
imag
fig
lesion
may
grow
larger
day
area
high
signal
intens
may
begin
reced
time
lesion
may
complet
resolv
tzweight
imag
relaps
defin
new
newli
enhanc
lesion
mr
imag
older
area
involv
may
reactiv
reactiv
associ
develop
perman
lesion
mr
imag
clinic
correl
frequent
observ
area
contrast
enhanc
abnorm
signal
intens
cerebellum
brainstem
spinal
cord
abnorm
cerebr
hemispher
frequent
periventricular
distribut
occasion
correl
specif
symptom
accumul
lesion
frontal
lobe
associ
declin
addit
chang
number
lesion
cranial
mr
imag
correl
chang
overal
clinic
statu
measur
standard
scalesg
observ
made
mri
mark
impact
basic
knowledg
ms
therapeut
trialsjo
mri
studi
provid
consider
insight
natur
histori
diseas
excel
independ
variabl
futur
clinic
trial
tradit
ms
thought
rel
high
incid
northernmost
latitud
northern
hemispherel
theori
base
incid
diseas
scandinavia
northern
unit
state
similar
associ
document
southern
hemispher
australia
new
zealand
observ
supplement
data
igrat
studi
demonstr
relat
age
igrat
assumpt
diseas
risk
locat
risk
confer
exposur
environ
certain
popul
suscept
ms
certain
popul
resist
ms
exampl
lapp
scandinavia
low
incid
ms
even
though
resid
predominantli
far
northern
latitud
north
america
diseas
infrequ
among
hutterit
nativ
american
ms
uncommon
japan
incid
diseas
firstdegre
rel
patient
ms
time
gener
suggest
genet
factor
influenc
diseas
express
result
populatidnbas
studi
twin
offer
evid
environment
genet
factor
contribut
develop
ms
investig
show
concord
monozygot
twin
greater
less
dizi
gotic
twinp
suggest
although
genet
factor
import
environment
exposur
also
import
diseas
express
commonli
accept
multipl
gene
influenc
autoimmun
diseas
anim
human
therefor
polygen
inherit
postul
ms
like
autoimmun
diseas
ms
frequent
women
ratio
l
patholog
featur
multipl
sclerosi
first
describ
charcot
l
recogn
plaqu
inth
white
matter
scleros
en
plaqu
patholog
examin
brain
section
plaqu
demonstr
lack
myelin
contain
perivascular
inflamm
featur
establish
patholog
hallmark
ms
follow
discuss
center
typic
find
ms
comparison
made
ms
form
inflammatori
demyelin
diseas
distribut
plaqu
within
white
matter
restrict
central
nervou
system
cn
plaqu
found
frequent
periventricular
distribut
cerebr
hemispher
plaqu
may
associ
distribut
termin
plaqu
may
occur
anywher
within
white
matter
plaqu
near
cortex
spare
subcort
myelin
fiber
often
observ
plaqu
adjac
gray
matter
may
time
spread
gray
matter
includ
cortex
deeper
nuclei
plaqu
frequent
found
white
matter
optic
nerv
brainstem
cerebellum
spinal
cord
plaqu
locat
frequent
correl
symptom
within
plaqu
axon
frequent
preserv
evolut
plaqu
known
mri
investig
show
bloodbrain
barrier
local
disrupt
onset
symptom
pathologist
disagre
whether
demyelin
preced
inflamm
secondari
inflamm
present
latter
view
predomin
acut
plaqu
inflammatori
respons
lymphocyt
plasma
cell
macrophag
capabl
produc
augment
demyelin
direct
indirect
mechan
inflammatori
respons
predominantli
perivenular
lesser
respons
edg
within
plaqu
macrophag
associ
acut
plaqu
characterist
contain
myelin
fragment
myelin
breakdown
productslg
lymphocyt
may
contribut
patholog
process
mean
direct
indirect
pathway
direct
mechan
includ
antibodyand
cellmedi
immun
tcellmedi
reactiv
favor
inflammatori
cell
cell
indirect
mechan
includ
secret
lymphokin
cytokin
abil
molecul
tumor
necrosi
factor
damag
myelin
oligodendrocyt
focu
ongo
cytokin
may
influenc
macrophag
activ
stimul
phagocytosi
myelin
addit
releas
heat
shock
protein
may
result
stimul
cell
result
increas
cytotox
cn
lesion
ms
classifi
earli
activ
activ
inact
earli
remyelin
late
remyelin
accord
histolog
criteria
featur
lesion
detail
tabl
studi
oligodendrocyt
earli
cours
ms
demonstr
rel
preserv
cell
patient
remyelin
possibl
patient
patient
strike
loss
oligodendrocyt
make
remyelin
unlik
differ
may
reflect
sever
injuri
specif
site
demyelin
may
indic
pathogenesi
demyelin
vari
among
patient
ms
may
impli
autoimmun
basi
ms
long
suspect
inflamm
cn
presenc
oligoclon
band
cerebrospin
fluid
csf
inflammatori
respons
primarili
lymphocyt
predomin
cell
among
lymphocyt
led
investig
evalu
role
tcell
receptor
recognit
antigen
combin
major
histocompat
antigen
mhc
name
trimolecular
tcell
receptor
recogn
antigen
context
mhc
molecul
case
mhc
class
ii
molecul
drz
antigen
fragment
bound
cleft
present
tcell
receptor
recognit
regard
compon
context
trimolecular
complex
import
note
ms
associ
certain
mhc
human
leukocyt
antigen
hla
marker
consist
observ
associ
haplotyp
differ
hla
associ
report
within
ethnic
group
mhc
molecul
may
contribut
genet
suscept
disord
one
number
factor
confer
risk
presenc
oligoclon
band
csf
patient
ms
frequent
observ
fig
abnorm
immunoglobulin
identifi
high
percentag
patient
clinic
definit
ms
present
approxim
patient
clinic
onset
diseas
oligoclon
band
ms
unknown
specif
small
percentag
may
bind
known
viral
antigen
patient
consist
bind
antibodi
specif
viral
polypeptid
viral
oligopeptid
homolog
myelin
compon
yet
demonstr
oligoclon
band
specif
ms
observ
patient
cn
infect
syphili
subacut
scleros
panenceph
viral
enceph
mening
infect
selflimit
oligoclon
band
may
transitori
abnorm
comparison
chronic
infect
cn
associ
persist
oligoclon
band
set
antibodi
compos
oligoclon
band
pathogen
specif
oligoclon
band
observ
patient
autoimmun
diseas
system
lupu
erythematosu
probabl
environment
factor
involv
pathogenesi
ms
stimul
interest
viral
caus
although
viral
isol
report
cn
patient
consist
observ
attempt
detect
viral
nucleic
acid
mean
situ
hybrid
polymeras
chain
reaction
pcr
progress
techniqu
extrem
sensit
requir
rigor
control
care
confirm
futur
viral
isol
viral
nucleic
acid
multipl
laboratori
requir
recent
studi
tropic
spastic
paraparesi
demonstr
retroviru
human
tcell
lymphotrop
viru
type
htlvi
involv
pathogenesi
disord
share
clinic
featur
clear
howev
htlvi
pathogen
ms
remain
possibl
retroviru
endogen
retroviru
could
contribut
pathogenesi
ms
consider
interest
possibl
exposur
viru
may
lead
immunopatholog
condit
result
ms
particular
note
investig
demonstr
potenti
molecular
mimicri
produc
autoimmun
term
molecular
mimicri
aris
demonstr
share
homolog
normal
human
myelin
protein
viral
polypeptid
immun
respons
mount
viral
epitop
may
perpetu
exposur
share
region
normal
human
protein
ms
homolog
myelin
antigen
viral
peptid
establish
thu
mechan
could
result
cn
demyelin
viral
infect
autoimmun
could
also
result
superantigen
stimul
cell
viral
bacteri
protein
superantigen
capabl
bind
specif
tcell
receptor
protein
produc
nonspecif
stimul
rel
larg
number
cell
might
caus
clonal
expans
cell
reactiv
myelin
oligodendrocyt
anim
mqdel
demyelin
diseas
cn
demyelin
associ
inflamm
present
anim
model
experiment
allerg
encephalomyel
eae
theiler
murin
encephalomyel
tme
model
provid
opportun
investig
autoimmun
virusassoci
diseas
respect
eae
autoimmun
diseas
cn
model
immunotherapi
tcell
popul
specif
myelin
antigen
either
mbp
proteolipid
protein
requir
initi
eae
eae
ms
share
characterist
includ
cn
demyelin
perivascular
cell
associ
mhc
class
ii
antigen
possibl
restrict
tcr
vgene
murin
adopt
transfer
model
anoth
import
featur
ms
chronic
relaps
clinic
clinic
cours
use
investig
immun
respons
immunotherapi
onset
diseas
also
relaps
patholog
featur
murin
transfer
model
inflamm
promin
eae
associ
environment
factor
tme
model
immunemedi
demyelin
particular
interest
import
parallel
postinfecti
encephalomyel
ms
model
anteced
mild
even
subclin
viral
enceph
follow
period
quiescenc
eventu
onset
demyelin
viru
persist
demyelin
phase
diseas
impli
either
lowlevel
express
viral
polypeptid
immunolog
crossreact
viru
myelin
antigen
crucial
initi
demyelin
demyelin
tme
viru
model
mediat
lymphocyt
cell
may
viral
specif
produc
demyelin
mechan
would
relev
ms
suspect
environment
factor
one
sever
virus
ms
eae
cell
appear
initi
immunemedi
demyelin
tme
z
experiment
immunotherapi
evalu
anim
model
provid
basi
clinic
trial
human
be
exampl
investig
treatment
includ
cytokin
transform
growth
antitcel
receptor
vbspecif
monoclon
tcell
block
peptid
antiadhes
molecul
specif
monoclon
nitric
oxid
synthetas
inhibit
experiment
model
provid
invalu
resourc
studi
immunotherapi
although
experiment
model
like
mirror
pathogenesi
ms
extrem
use
studi
cn
inflamm
demyelin
ms
primarili
diseas
young
adult
patient
report
first
symptom
age
year
disord
rare
appear
age
year
age
year
although
report
occur
children
elderli
symptom
ms
children
essenti
adult
ataxia
numb
visual
disturb
common
present
symptom
elderli
person
progress
onset
common
ms
character
episod
neurolog
dysfunct
follow
period
stabil
remiss
symptom
appear
may
partial
complet
resolv
may
perman
episod
tend
develop
hour
day
sometim
symptom
occur
almost
strokelik
sudden
may
develop
slowli
week
symptom
develop
resolut
gener
occur
week
month
certain
sign
symptom
common
earli
stage
ms
includ
numb
doubl
vision
monoparesi
paraparesi
bladder
control
problem
optic
neuriti
ataxia
tremor
tabl
dm
januari
numb
difficult
evalu
numb
suggest
earli
ms
includ
ascend
numb
begin
feet
may
sign
transvers
myeliti
hemiparesthesia
bilater
hand
numb
dysesthesia
hand
feet
one
side
bodi
also
earli
symptom
ms
numb
usual
present
day
week
month
mani
patient
describ
numb
paresthesia
object
abnorm
object
sensori
abnorm
occur
commonli
reduct
vibrat
propriocept
stereognosi
rather
pain
fever
diplopia
occur
ms
frequent
partial
complet
internuclear
ophthalmoplegia
often
bilater
small
percentag
patient
sixth
nerv
palsi
rare
third
fourth
nerv
palsi
ww
sometim
monocular
diplopia
symptom
optic
neuriti
optic
neuriti
usual
character
monocular
blur
vision
sometim
scotomata
often
alter
color
vision
retroorbit
pain
headach
common
patient
activ
optic
neuriti
pain
may
intensifi
eye
movement
motor
weak
usual
accompani
upper
motor
neuron
sign
hyperreflexia
babinski
sign
paraparesi
common
earli
symptom
weak
also
occur
hemiparesi
monoparesi
spastic
later
manifest
sign
symptom
commonli
occur
ms
progress
includ
vertigo
tremor
incoordin
increas
spastic
depress
mood
swing
cognit
abnorm
impot
sexual
dysfunct
weak
lhermitt
sign
gait
abnorm
constip
urinari
incontin
optic
nerv
pallor
fatigu
quadriparesi
dysarthria
loss
upper
extrem
coordin
dysesthet
pain
tabl
uncommon
import
problem
includ
seizur
atyp
facial
pain
tic
douloureux
trigemin
neuralgia
bowel
incontin
swallow
problem
hear
loss
dystonia
bell
palsi
sometim
seen
patient
ms
tabl
classic
cours
ms
one
intermitt
neurolog
sign
symptom
mani
year
time
progress
chronic
problem
accumul
amount
total
disabl
vari
patient
patient
number
year
patient
condit
may
stabil
perman
alway
occur
f
januari
subtyp
diseas
ms
divid
subtyp
accord
cours
diseas
continuum
among
variou
subtyp
diseas
patient
fit
pattern
benign
ms
account
case
occur
often
young
women
type
ms
symptom
mild
often
sensori
resolut
neurolog
problem
nearli
complet
year
patient
rare
experi
consider
disabl
relapsingremit
ms
common
form
diseas
character
episod
neurolog
dysfunct
variabl
call
exacerb
relaps
attack
follow
period
improv
stabil
call
remiss
remiss
symptom
resolv
complet
patient
may
left
perman
disabl
may
vari
sever
condit
patient
initi
relapsingremit
cours
begin
worsen
gradual
time
neurolog
sign
symptom
accumul
form
diseas
classifi
secondari
chronic
progress
ms
relapsingprogress
ms
latter
term
also
use
describ
diseas
patient
sudden
deterior
stepwis
manner
without
clinic
signific
recoveri
primaryprogress
ms
occur
patient
diseas
patient
begin
slow
progress
neurolog
deficit
histori
relaps
may
also
period
stabil
subacut
worsen
common
problem
appear
gradual
worsen
time
includ
spastic
paraparesi
cerebellar
ataxia
urinari
incontin
clinic
find
although
neurolog
find
pathognomon
ms
certain
abnorm
found
physic
examin
help
provid
clue
diagnosi
ms
includ
internuclear
ophthalmoplegia
rare
seen
diseas
especi
rare
young
adult
hyperreflexia
babinski
sign
common
earli
ms
optic
nerv
pallor
provid
clue
subclin
resolv
optic
neuriti
alter
color
vision
one
eye
marcusgunn
pupil
also
sign
optic
neuriti
nystagmu
common
find
patient
ms
mani
type
nystagmu
identifi
includ
pendular
nystagmu
smallamplitud
nystagmu
gazeevok
absent
abdomin
reflex
slender
patient
undergon
abdomin
oper
may
help
sign
mild
intent
tremor
without
pastpoint
also
earli
sign
posit
romberg
sign
difficulti
balanc
divz
januari
tandem
gait
subtl
motor
weak
spastic
may
also
found
loss
vibratori
propriocept
sensat
lower
extrem
common
earli
cours
diseas
ms
strongli
suspect
young
middleag
adult
describ
symptom
consist
lhermitt
sign
absenc
obviou
cervic
cord
abnorm
lhermitt
sign
consist
paresthesia
electr
shocklik
sensat
radiat
head
spine
neck
flexion
extens
import
abnorm
gait
disturb
persist
binocular
doubl
vision
look
particular
direct
histori
optic
neuriti
transvers
myeliti
fatigu
depress
criteria
diagnosi
ms
laboratori
test
univers
diagnost
ms
certain
studi
help
confirm
presenc
separ
lesion
space
time
examin
csf
valuabl
two
reason
first
pattern
csf
find
help
confirm
presenc
demyelin
diseas
protein
level
often
slightli
elev
rare
greater
gl
unless
patient
experienc
sever
exacerb
particularli
optic
neuriti
transvers
myeliti
modest
elev
cell
count
gener
less
seen
patient
cell
pattern
usual
consist
mostli
mononuclear
cell
sophist
test
conduct
cell
identifi
lymphocyt
qualit
analysi
protein
help
suggest
diagnosi
ms
electrophoresi
oligoclon
immunoglobulin
band
identifi
csf
serum
mani
patient
ms
fig
igg
index
comparison
igg
level
csf
igg
level
serum
elev
mani
patient
ms
although
find
suggest
ms
also
found
diseas
commonli
inflammatori
diseas
cn
diseas
includ
lyme
diseas
system
lupu
erythematosu
progress
multifoc
leukoencephalopathi
enceph
subacut
scleros
panenceph
ver
abnorm
approxim
patient
ms
regardless
whether
histori
optic
slow
ploo
patient
without
histori
optic
neuriti
paraclin
evid
second
lesion
use
confirm
diagnosi
ms
fig
baer
difficult
interpret
ver
abnorm
approxim
patient
ms
baer
five
z
januari
consecut
wave
identifi
number
iv
wave
interv
iiii
consid
peripher
system
abnorm
wave
suggest
lesion
peripher
auditori
nerv
wave
interv
iiiv
gener
central
hear
area
brainstem
slow
area
suggest
brainstem
lesion
abnorm
wave
iiiv
seen
approxim
patient
ms
sser
technic
difficult
studi
respons
use
identif
slow
central
conduct
sensori
pathway
spinal
cord
brain
sser
abnorm
approxim
patient
definit
ms
sser
also
use
identif
peripher
lesion
suggest
peripher
neuropathi
rather
central
lesion
caus
numb
develop
mri
extrem
import
make
diagnosi
ms
help
research
understand
dynam
ms
patient
diseas
mri
find
interpret
caution
howev
abnorm
mri
find
alon
suffici
confirm
diagnosi
ms
without
clinic
evid
patient
ms
patchi
area
abnorm
white
matter
seen
weight
spinecho
imag
commonli
found
cerebr
hemispher
periventricular
area
patient
howev
lesion
also
identifi
brainstem
cerebellum
mri
also
help
identifi
lesion
cervic
thorac
spinal
cord
gadolinium
enhanc
seen
around
lesion
particularli
patient
exacerb
fairli
rapid
chronic
progress
gadolinium
enhanc
consid
sign
activ
lesion
tabl
mr
imag
interpret
caution
particularli
patient
chronic
ill
kind
patient
older
year
fazeka
et
attempt
differenti
mr
imag
healthi
person
older
year
patient
ms
identifi
follow
three
criteria
diagnosi
ms
lesion
abut
later
ventricl
lesion
diamet
greater
cm
lesion
present
posterior
fossa
two
three
criteria
met
specif
ms
sensit
followup
studi
consecut
mri
examin
yield
sensit
specif
criteria
may
use
interpret
mri
find
patient
use
caution
patient
diseas
affect
mri
hypertens
diabet
mellitu
patient
diseas
exclud
studi
fazeka
et
al
size
area
lesion
present
mr
imag
correl
poorli
patient
disabl
mani
patient
larg
lesion
mr
imag
minor
clinic
find
wherea
patient
small
lesion
sever
disabl
one
area
mri
may
indic
sever
problem
cognit
statu
patient
increas
area
lesion
cerebr
hemispher
thin
corpu
callosum
may
correl
poor
cognit
function
presenc
lesion
spinal
cord
correl
diseas
sever
recent
studi
bodi
coil
imag
use
show
patient
ms
lesion
spinal
cord
identifi
techniqu
although
presenc
lesion
area
number
lesion
correl
patient
level
disabl
presenc
spinal
cord
atrophi
correl
greater
disabl
patient
partial
complet
transvers
myeliti
subsequ
found
ms
often
lesion
mr
imag
correspond
level
indic
symptom
level
neurolog
find
simnad
v
rose
jw
manuscript
prepar
use
mri
followup
evalu
ms
becom
integr
part
research
cours
diseas
howev
mri
find
correl
patient
clinic
condit
new
abnorm
mr
imag
absenc
clinic
worsen
treat
exacerb
diseas
new
abnorm
howev
indic
diseas
remain
activ
mri
repeat
patient
diagnosi
confirm
patient
new
symptom
suggest
second
diseas
choic
treatment
ms
increas
monitor
diseas
activ
may
becom
use
determin
cours
treatment
optic
neuriti
often
seen
first
demyelin
episod
patient
ms
diagnosi
ms
consid
patient
optic
neuriti
care
histori
examin
perform
exclud
neurolog
abnorm
howev
mani
patient
singl
episod
optic
neuriti
never
demyelin
episod
one
studi
patientsgo
found
ms
develop
women
men
within
year
attack
optic
neuriti
transvers
myeliti
inflamm
area
spinal
cord
caus
ascend
weak
numb
level
lesion
also
seen
initi
demyelin
event
ms
caus
includ
infecti
postinfecti
postvaccin
demyelin
sometim
caus
never
determin
transvers
myeliti
occur
imflammatori
lesion
identifi
mri
imag
cervic
thorac
spinal
cord
estim
risk
ms
isol
episod
transvers
myeliti
rang
im
z
januari
use
cranial
mr
imag
patient
optic
neuriti
transvers
myeliti
may
help
predict
patient
like
addit
problem
one
prospect
studi
identifi
patient
singl
demyelin
episod
optic
neuriti
transvers
myeliti
patient
abnorm
mri
find
time
first
episod
risk
second
episod
within
year
patient
normal
mri
find
time
first
episod
risk
develop
second
lesion
syndrom
optic
neuriti
transvers
myeliti
develop
demyelin
event
call
devic
neuromyel
optica
disord
cranial
mri
find
remain
normal
consid
monophas
illnessboth
abnorm
occur
within
year
patient
may
never
anoth
demyelin
event
rare
follow
characterist
associ
favor
prognosi
femal
sex
earli
age
onset
onset
symptom
refer
singl
neurolog
system
substanti
recoveri
relaps
earli
symptom
numb
rather
corticospin
cerebellar
symptom
unfavor
prognosi
associ
chronic
progress
diseas
either
primari
secondari
older
age
onset
male
dlagnost
criteria
difficulti
involv
diagnosi
ms
sever
criteria
publish
standard
term
use
describ
certainti
diagnosi
two
primari
set
criteria
poser
et
shumach
et
poser
criteria
recent
summar
tabl
import
rememb
abnorm
use
criterion
explain
anoth
medic
problem
condit
may
commonli
confus
ms
consid
differenti
diagnosi
differenti
diagnosi
depend
part
clinic
laboratori
find
individu
patient
postinfecti
encephalomyel
subacut
syndrom
possibl
caus
autoimmun
respons
viral
infect
patient
ill
experi
acut
subacut
onset
confus
disorient
gait
abnorm
loss
bowel
bladder
control
weak
symptom
abnorm
white
mat
ter
seen
mri
evid
inflamm
frequent
seen
cse
patient
condit
may
may
return
normal
recoveri
may
take
month
even
year
lyme
diseas
promin
concern
appear
caus
intermitt
neurolog
event
common
bell
palsi
encephalomyel
may
develop
vagu
symptom
numb
fatigu
memori
deficit
abnorm
white
matter
may
seen
mri
csf
find
may
resembl
ms
includ
mild
leukocytosi
oligoclon
band
patient
may
histori
tick
bite
rash
recent
arthralgia
lyme
titer
lyme
pcr
blood
csf
may
help
patient
system
lupu
erythematosu
wellknown
syndrom
may
caus
transvers
myeliti
stroke
encephalopathi
optic
abnorm
clue
differenti
diagnosi
system
abnorm
hematuria
leukopenia
arthriti
elev
antinuclear
antibodi
titer
erythrocyt
sediment
rate
blood
measur
sometim
system
lupu
erythematosu
ms
occur
patient
primari
cn
vascul
caus
syndrom
similar
ms
differenti
featur
includ
promin
headach
confus
sudden
strokelik
episod
elev
erythrocyt
sediment
rate
may
present
patient
may
elev
csf
protein
level
patient
may
abnorm
cerebr
angiogram
biopsi
tempor
lobe
mening
may
help
diagnosi
syndrom
htlvi
retroviru
caus
syndrom
known
tropic
spastic
paraparesi
htlviassoci
myelopathi
may
caus
progress
spastic
paraparesi
gener
white
matter
diseas
htlvi
rel
rare
unit
state
present
patient
resid
around
caribbean
sea
behqet
syndrom
caus
mri
find
ident
ms
cardin
featur
behqet
syndrom
includ
oral
ulcer
genit
ulcer
uveiti
variabl
featur
includ
involv
skin
eye
joint
lung
intestin
heart
venou
thrombosi
neuropsychiatr
symptom
includ
quadriparesi
pseudobulbar
palsi
cranial
neuropathi
cerebellar
ataxia
peripher
neuropath
lesion
cerebr
venou
thrombosi
may
sarcoidosi
sjggren
syndrom
autoimmun
diseas
may
show
lesion
mr
imag
resembl
ms
mening
enhanc
clue
cn
sarcoidosi
chest
radiograph
may
show
granulomat
lesion
suggest
system
sarcoidosi
although
igg
level
rais
csf
patient
cn
sarcoidosi
oligoclon
band
found
patient
csf
angiotensinconvert
enzym
determin
may
use
differenti
cn
sarcoidosi
vitamin
b
defici
syphili
caus
posterior
column
abnormali
dementia
test
problem
perform
patient
symptom
seen
certain
leukodystrophi
may
appear
adulthood
includ
adren
leukodystrophi
krabb
diseas
metachromat
leukodystrophi
mri
find
diseas
show
larg
area
normal
white
matter
present
femal
carrier
adren
leukodystrophi
gene
may
mslike
hereditari
degen
syndrom
famili
spastic
paraparesi
olivopontocerebellar
degener
spinocerebellar
degener
may
confus
ms
particularli
primari
progress
ms
diseas
mr
imag
may
normal
may
show
atrophi
brainstem
spinal
cord
cerebellum
csf
normal
patient
studi
support
concept
exercis
benefici
patient
msggjoo
simpl
measur
walk
use
exercis
bicycl
swim
may
consider
valu
exercis
perform
cool
environ
whenev
possibl
prevent
heatassoci
transient
declin
neurolog
function
swim
water
aerob
pool
overli
heat
particularli
valuabl
patient
cool
exercis
physic
occup
therapi
often
invalu
mainten
improv
neurolog
function
brace
disabl
portion
limb
particularli
ankl
provid
consider
benefit
exercis
regimen
tailor
patient
may
help
maintain
improv
strength
rang
motion
mobil
devic
provid
assist
walk
import
reduc
risk
fall
allow
greater
independ
increas
activ
assist
devic
help
reduc
fatigu
increas
independ
activ
care
consult
specialist
rehabilit
medicin
assist
patient
manag
work
daili
activitiesl
advis
person
ms
maintain
balanc
diet
weight
control
promin
concern
overweight
patient
motor
sensori
coordin
deficit
impair
ambul
particular
risk
fall
may
result
seriou
injuri
includ
fractur
patient
overweight
whose
strength
decreas
lose
reserv
strength
may
weight
patient
ms
lose
weight
requir
dietari
supplement
patient
dysphagia
may
requir
feed
tube
help
prevent
aspir
pneumonia
although
variou
diet
advoc
ms
substanti
data
control
trial
support
assert
gener
health
measur
commonli
suggest
patient
ms
restrict
cholesterol
fat
diet
diet
meet
requir
american
heart
associ
like
use
patient
ms
live
middl
age
beyond
pregnanc
concern
among
young
women
ms
mani
studi
effect
pregnanc
ms
undertaken
increas
risk
exacerb
first
month
postpartum
howev
risk
exacerb
pregnanc
appear
unchang
slightli
overal
longterm
disabl
appear
alter
increas
relaps
rate
seen
postpartum
period
postul
caus
increas
immun
toler
pregnanc
follow
return
normal
postpartum
dm
januari
period
also
postul
relaps
secondari
decreas
level
femal
hormon
parturitionlo
addit
physic
effect
pregnanc
anoth
major
concern
care
infant
child
person
physic
problem
person
ms
need
consid
care
whether
handl
addit
work
care
child
person
chronic
physic
problem
may
need
special
provis
extra
assist
home
special
equip
physician
discuss
pregnanc
deliveri
child
care
women
childbear
age
increas
core
temperatur
whether
due
heat
exposur
febril
respons
may
lead
transient
increas
neurolog
event
due
heat
exposur
patient
simpli
need
rest
cool
environ
await
recoveri
infect
respons
sourc
infect
determin
treat
antipyret
medic
acetaminophen
administ
mani
patient
ms
suscept
urinari
tract
infect
may
clinic
manifest
infect
patient
due
impair
sensori
capabl
patient
chronic
urinari
symptom
may
chang
substanti
infect
one
studi
ms
exacerb
point
associ
anteced
patient
persist
worsen
infect
appropri
treat
resolv
steroid
therapi
consid
event
infect
recur
relaps
consid
onset
new
neurolog
symptom
mark
worsen
old
symptom
last
longer
hour
certain
condit
may
mimic
exacerb
rule
treat
steroid
therapi
consid
includ
fever
infect
commonli
urinari
tract
infect
viral
ill
overh
fatigu
sever
emot
stress
effect
medic
baclofen
increas
weak
problem
appropri
treat
patient
condit
usual
improv
mild
relaps
may
best
treat
without
steroid
therapi
symptom
includ
mild
numb
mild
chang
bladder
function
mild
optic
neuriti
visual
acuiti
better
slight
increas
spastic
dysesthet
pain
syndrom
new
abnorm
chang
person
abil
perform
usual
daili
activ
may
requir
steroid
therapi
patient
rest
sometim
help
patient
sever
worsen
may
benefit
steroid
therapi
symptom
includ
gait
disturb
sever
numb
paresthesia
moder
sever
paresi
moder
sever
optic
neuriti
sever
vertigo
mark
impair
eye
movement
often
appropri
physician
observ
patient
day
make
decis
use
steroid
standard
therapi
mani
year
immunosuppress
corticotropin
acth
steroid
use
treatment
exacerb
ms
primari
effect
agent
shorten
durat
attack
benefit
proven
overal
outcom
attack
steroid
given
abnorm
resolv
may
never
occur
acth
first
immunosuppress
wide
use
although
still
given
patient
respond
well
medic
acth
larg
supplant
steroid
commonli
prednison
methylprednisolon
mani
differ
regimen
use
typic
regimen
unit
intraven
intramuscular
inject
day
day
prednison
commonli
use
mild
moder
exacerb
ms
although
low
dose
appear
effect
exacerb
larger
dose
appear
shorten
durat
ms
attacklog
standard
treatment
regimen
dose
least
mgkg
per
day
commonli
recommend
continu
day
regimen
mg
day
mouth
day
taper
mg
everi
day
regimen
rang
day
week
longer
methylprednisolon
sodium
succin
solumedrol
often
use
treatment
sever
relaps
patient
condit
continu
worsen
sever
day
highdos
prednison
lo
typic
dosag
rang
mgday
last
day
typic
dose
mg
ml
dextros
water
minut
everi
hour
total
dose
anoth
mg
ml
dextros
water
minut
everi
hour
dose
oral
prednison
taper
day
week
may
use
afterward
one
studi
optic
neuriti
suggest
highdos
methylprednisolon
produc
favor
result
oral
prednison
patient
poor
visual
acuiti
studi
show
faster
recoveri
time
followup
examin
year
show
differ
final
outcom
l
studi
involv
patient
necessarili
diagnosi
ms
howev
followup
evalu
patient
ms
subsequ
develop
suggest
methylprednisolonetr
group
longer
time
interv
develop
second
demyelin
event
dm
januari
receiv
prednison
reason
neurologist
believ
attack
ms
treat
intraven
methylprednisolon
side
effect
steroid
well
known
includ
nonspecif
immunosuppress
lead
opportunist
infect
induct
hyperglycemia
fluid
retent
hypertens
emot
abnorm
hypokalemia
peptic
ulcer
occasion
asept
necrosi
femor
head
bone
deminer
bone
chronic
use
may
lead
cataract
osteoporosi
muscl
wast
hypertens
diabet
increas
suscept
infect
cushingoid
appear
steroid
use
caution
found
follow
precaut
help
administr
calcium
possibl
vitamin
administr
steroid
restrict
food
high
sugar
sodium
content
encourag
patient
eat
food
rich
potassium
banana
orang
juic
tomato
patient
experi
indigest
may
benefit
use
histamin
blocker
ranitidin
patient
may
need
sedat
diazepam
agent
sever
mood
swing
anxieti
sleepless
patient
receiv
high
dose
methylprednisolon
observ
hypertens
electrolyt
imbal
hyperglycemia
problem
treat
appropri
occasion
psychiatr
symptom
includ
depress
psychosi
sever
anxieti
may
necessit
cessat
steroid
therapi
betaseron
recombin
interferon
approv
us
food
drug
administr
fda
use
ambulatori
patient
relapsingremit
ms
approv
follow
control
doubleblind
studi
show
patient
treat
million
unit
betaseron
administ
subcutan
everi
day
relaps
rate
reduc
relaps
per
year
compar
relaps
per
year
patient
given
mri
studi
perform
popul
reveal
fewer
new
lesion
treatment
group
control
grouplo
drug
improv
ongo
symptom
studi
limit
patient
relapsingremit
diseas
find
extrapol
patient
chronic
progress
diseas
studi
use
betaseron
patient
chronic
progress
ms
plan
patient
whose
condit
stabl
would
benefit
use
betaseron
problem
use
betaseron
although
drug
may
help
patient
frequent
relaps
seriou
side
effect
almost
patient
experi
local
reaction
site
inject
patient
tissu
necrosi
inject
site
inject
site
must
chang
regularli
reduc
likelihood
ulcer
mani
patient
flulik
reaction
may
includ
fever
chill
malais
myalgia
reaction
resolv
time
commonli
last
month
howev
may
last
long
year
symptom
partial
control
acetaminophen
ibuprofen
liver
function
studi
may
show
abnorm
leukopenia
may
present
fatigu
emot
disturb
report
patient
experienc
episod
acut
depress
anxieti
one
patient
episod
uncontrol
rage
depress
may
necessit
temporari
perman
cessat
betaseron
treatment
howev
antidepress
fluoxetin
sertralin
paroxetin
hydrochlorid
may
help
counteract
depress
case
ms
appear
worsen
patient
take
betaseron
acut
weak
develop
patient
first
inject
alway
associ
fever
may
resolv
time
menstrual
irregular
report
betaseron
use
pregnanc
patient
toler
medic
better
full
dose
titrat
approxim
month
period
blood
test
check
leukopenia
abnorm
liver
function
suggest
clinic
trial
prepar
interferona
near
complet
one
clinic
trial
involv
administr
weekli
intramuscular
inject
result
suggest
drug
reduc
likelihood
progress
patient
earli
diseas
phase
iii
clinic
trial
anoth
investig
agent
copolym
complet
drug
appear
promis
reduc
relaps
good
safeti
agent
like
avail
near
futur
pend
fda
approv
although
treatment
aim
chronic
progress
remain
experiment
use
intermitt
intraven
methylprednisolon
becom
common
practic
commonli
patient
experi
subacut
worsen
may
respond
cours
highdos
solumedrol
similar
given
sever
relaps
condit
patient
appear
stabil
least
temporarili
cours
therapi
patient
progress
diseas
may
respond
singl
dose
mg
solumedrol
ml
dextros
water
given
hour
month
month
subsequ
treatment
may
given
everi
week
azathioprin
use
treatment
chronic
progress
success
studi
shown
modest
benefit
azathioprin
primarili
stabil
condit
patient
take
drug
examin
leukopenia
hepatotox
patient
unabl
toler
azathioprin
fever
rash
nausea
patient
continu
progress
therapi
azathioprin
solumedrol
may
benefit
combin
therapi
cyclosporin
evalu
multicent
clinic
trial
found
modest
clinic
benefitllg
prolong
use
cyclosporin
patient
chronic
progress
ms
complic
side
effect
princip
nephrotox
hypertens
use
cyclophosphamid
treatment
chronic
progress
ms
result
clinic
trial
agent
chronic
progress
ms
contradictori
drug
may
use
rapidli
progress
ms
respond
steroid
therapi
investig
mri
neuropsycholog
test
care
clinic
assess
resolv
controversi
number
promis
phase
iii
clinic
trial
therapeut
agent
relapsingremit
ms
conduct
two
agent
placebocontrol
phase
complet
interferon
given
week
intramuscular
inject
copolym
drug
reduc
frequenc
relaps
favor
influenc
disabl
ident
human
differ
betaseron
sequenc
amino
acid
glycosyl
human
result
review
safeti
profil
drug
compar
betaseron
consider
interest
copolym
appear
activ
similar
betaseron
regard
reduct
relaps
sideeffect
profil
appear
favor
compar
betaseron
laboratori
investig
demonstr
addit
effect
copolym
vitro
drug
theoret
act
differ
mechan
combin
therapi
might
possibl
result
pilot
studi
oral
myelin
test
phase
iii
clinic
trial
pilot
trial
efficaci
drug
observ
subgroup
patient
men
two
pilot
studi
use
methotrex
ms
methotrex
low
dose
use
treatment
rheumatoid
arthriti
psoriasi
crohn
diseas
similar
therapi
may
benefit
patient
advanc
phase
iii
control
trial
dose
respons
test
consider
interest
methotrex
use
clinic
set
allow
care
neurolog
laboratori
followup
evalu
dm
januari
cladribin
intraven
administr
appear
alter
progress
ms
drug
rel
select
toxic
lymphocyt
howev
side
effect
substanti
addit
studi
evalu
dose
rout
administr
initi
clinic
effect
repeat
dosag
medic
also
requir
studi
immunoglobulin
therapi
may
use
ms
howev
control
trial
intraven
immunoglobulin
ivig
must
therapi
may
use
relaps
diseas
consid
patient
ms
diabet
ivig
therapi
necessarili
benign
respons
transmiss
viral
hepat
sever
clinic
trial
monoclon
antibodi
progress
number
monoclon
antibodi
specif
either
lymphocyt
adhes
molecul
subject
initi
trial
human
be
monoclon
antibodi
appear
lower
lymphocyt
appreci
effect
lesion
patient
ms
seen
mr
imag
klptomtic
therapi
one
import
aspect
treatment
ms
help
patient
manag
ongo
symptom
chronic
natur
problem
associ
ms
medic
adjust
lifestyl
use
help
patient
cope
disabl
tabl
give
summari
possibl
symptomat
treatment
fatigu
disabl
patient
ms
describ
differ
way
differ
patient
classic
descript
fatigu
increas
weak
exercis
day
progress
patient
may
walk
fairli
well
morn
need
cane
walker
afternoon
descript
includ
sudden
attack
sleepi
excess
chronic
sleepi
even
though
patient
enough
sleep
nightlzg
patient
describ
fatigu
question
close
sleep
habit
symptom
depress
mani
patient
fatigu
may
poor
sleep
habit
insomnia
lead
daytim
fatigu
depress
common
problem
patient
fatigu
product
depress
treatment
depress
help
fatigu
sometim
manag
without
medic
patient
may
respond
one
two
brief
minut
nap
day
help
possibl
amantadin
may
given
help
control
problem
mechan
action
amantadin
known
help
approxim
patientslzg
side
effect
dizzi
headach
nervous
edema
may
limit
use
drug
pemolin
cn
stimul
may
help
use
low
dose
gener
given
earli
day
may
caus
insomnia
anxieti
anorexia
problem
may
occur
drug
liver
function
studi
perform
period
monitor
hepatotox
fluoxetin
prozac
may
help
increas
energi
treat
depress
z
januari
vertigo
vertigo
intract
disabl
problem
vertigo
occur
sudden
spell
last
minut
chronic
last
hour
physic
therapi
techniqu
involv
habitu
exercis
help
vertigo
medic
may
help
includ
meclizin
promethazin
hydrochlorid
lowdos
diazepam
oscillopsia
may
occasion
respond
clonazepam
baclofen
vertigo
nausea
vomit
may
respond
metoclopramid
spastic
appear
mani
differ
way
may
seen
direct
examin
catch
muscl
passiv
rapid
movement
limb
may
caus
sever
stiff
rigid
patient
may
sever
spasm
affect
limb
may
precipit
movement
occur
night
common
lower
limb
may
either
flexor
extensor
spasm
spasm
quit
pain
primari
treatment
spastic
includ
physic
therapi
stretch
exercis
combin
medic
baclofen
commonli
use
drug
spastic
although
mechan
action
known
dose
baclofen
low
treatment
begin
titrat
slowli
care
patient
take
overdos
baclofen
experi
weak
dose
baclofen
extrem
variablesom
patient
moder
spastic
toler
high
dose
wherea
other
sever
spastic
toler
low
dose
limit
side
effect
includ
drowsi
confus
nausea
use
baclofen
discontinu
abruptli
taper
diazepam
combin
baclofen
may
help
patient
sever
spastic
toler
high
dose
baclofen
need
control
spastic
diazepam
use
alon
spastic
effect
diazepam
particularli
help
flexor
extensor
spasm
night
dantrolen
limit
valu
hepatotox
weak
accompani
musclerelax
effect
may
help
intract
case
spastic
baclofen
pump
develop
use
patient
intract
spastic
devic
intrathec
pump
subcutan
reservoir
baclofen
administ
continu
dose
baclofen
directli
spinal
canal
method
administr
effect
lower
dose
deliv
directli
spinal
cord
patient
seem
fewer
side
effect
rout
administr
dose
level
program
chang
throughout
day
patient
problem
wors
night
anoth
part
day
take
increas
dose
drug
time
tizanidin
agent
use
outsid
unit
state
spastic
studi
unit
state
may
becom
avail
near
futur
agent
may
use
treatment
spastic
includ
carbamazepin
phenytoin
sodium
methocarbamol
cyclobenzaprin
hydrochlorid
clonidin
patch
may
use
adjunct
therapi
patient
persist
spasm
take
drug
spastic
dysarthria
uncommon
symptom
ms
speech
hesit
stutter
breath
control
difficult
baclofen
sometim
help
condit
bladder
dysfunct
extrem
common
problem
ms
examin
postvoid
residu
urin
volum
urodynam
test
extrem
import
delin
caus
bladder
dysfunct
urolog
examin
cystoscopi
may
help
elimin
mechan
problem
caus
urinari
dysfunct
consult
urologist
skill
evalu
neurolog
dysfunct
bladder
essenti
best
therapeut
outcom
common
problem
spastic
bladder
small
hyperact
bladder
symptom
type
bladder
dysfunct
urgenc
increas
frequenc
incontin
bladder
empti
complet
brief
warn
condit
treat
anticholinerg
agent
oxybutynin
propanthelin
sometim
baclofen
amitriptylin
use
control
problem
tabl
detrusorextern
sphincter
dyssynergia
common
problem
syndrom
bladder
attempt
empti
urethra
remain
close
symptom
may
urgenc
hesit
doubl
void
increas
frequenc
feel
incomplet
empti
anticholinerg
tricycl
agent
alon
may
help
syndrom
commonli
combin
anticholinerg
drug
intermitt
catheter
need
control
problem
patient
perform
selfcatheter
two
four
time
day
flaccid
bladder
less
common
type
bladder
dysfunct
enlarg
bladder
empti
poorli
symptom
includ
hesit
doubl
void
feel
incomplet
empti
dribbl
incontin
untreat
urinari
retent
result
hydronephrosi
urecholin
use
patient
frequent
howev
schedul
intermitt
selfcatheter
may
need
tabl
patient
flaccid
bladder
sphincter
dyssynergia
may
frequent
urinari
tract
infect
acidifi
agent
hippur
acid
vitamin
c
may
use
prevent
longterm
administr
antibiot
avoid
reduc
risk
z
patient
sever
bladder
problem
unrespons
noninvas
therapi
may
requir
chronic
indwel
cathet
urinari
divers
techniqu
may
requir
patient
perform
intermitt
selfcatheter
sexual
dysfunct
common
men
women
ms
women
often
report
decreas
sensat
lack
vagin
lubric
difficulti
achiev
orgasm
pain
muscl
spasm
leg
pelvi
intercours
men
report
diminish
sensat
difficulti
achiev
maintain
erect
experienc
orgasm
simpl
answer
sexual
problem
occur
ms
multidisciplinari
approach
need
physic
psycholog
aspect
sexual
problem
consid
women
treatment
muscl
spasm
medic
spastic
may
allow
intercours
less
pain
techniqu
increas
vagin
clitor
stimul
may
help
women
experi
orgasm
method
increas
arous
may
help
men
interview
determin
whether
caus
erectil
dysfunct
medic
may
affect
erectil
function
elimin
possibl
yohimbin
receptor
antagonist
sometim
help
restor
function
patient
borderlin
function
method
includ
papaverin
phentolamin
inject
vacuum
erectil
devic
penil
prosthesi
may
inappropri
affect
problem
patient
ms
mani
patient
sever
mood
swing
affect
work
social
relationship
lowdos
amitriptylin
anoth
tricycl
antidepress
frequent
help
control
mood
depress
common
problem
suicid
rate
among
person
ms
estim
time
healthi
popul
whether
depress
primari
symptom
ms
situat
problem
known
physician
alert
possibl
depress
patient
fulldos
antidepress
medic
psycholog
counsel
may
benefici
tremor
limit
factor
mani
patient
ms
treatment
medic
frequent
unsuccess
agent
may
use
includ
clonazepam
acetazolamid
propranolol
primidon
diazepam
isoniazid
report
help
patient
found
clonazepam
help
agent
patient
treatment
may
limit
drowsi
common
misconcept
pain
symptom
patient
ms
truth
pain
often
problem
may
promin
concern
patient
primari
factor
diseas
consequ
disabl
associ
diseas
much
pain
report
ms
musculoskelet
relat
abnorm
use
muscl
joint
exampl
patient
use
wheelchair
may
experi
wrist
shoulder
elbow
pain
manipul
wheelchair
patient
paraparesi
ataxia
may
experi
back
leg
pain
poor
postur
balanc
walk
problem
treat
antiinflammatori
medic
physic
therapi
primari
ms
pain
often
patient
describ
burn
sensat
perhap
even
electr
shocklik
pain
pain
locat
commonli
lower
extrem
patient
experi
tic
douloureux
atyp
facial
pain
primari
pain
may
control
tricycl
antidepress
phenytoin
patient
refractori
pain
valproic
acid
tri
headach
becom
problem
patient
ms
known
whether
headach
caus
ms
separ
problem
tension
migrain
headach
common
treatment
similar
treatment
headach
patient
ms
retroorbit
pain
frequent
observ
patient
optic
neuriti
patient
may
requir
steroid
therapi
spastic
muscl
spasm
caus
sever
pain
treatment
spastic
help
pain
mani
patient
ms
experi
cognit
abnorm
unlik
dementia
alzheim
diseas
cognit
deficit
seem
scatter
tend
retriev
deficit
rather
memori
loss
patient
substanti
cognit
difficulti
still
normal
miniment
state
examin
find
neuropsycholog
studi
shown
mani
patient
may
cognit
difficulti
import
term
disabl
abil
cope
ill
minor
patient
sever
cognit
abnorm
mr
imag
patient
cognit
problem
tend
show
larger
number
size
lesion
white
matter
cerebr
hemispher
frontal
lesion
common
patient
cognit
difficulti
corpu
callosum
may
thinner
normal
seen
sagitt
patient
cognit
problem
undergo
care
neuropsychiatr
test
sometim
depress
anxieti
contribut
factor
symptom
minnesota
multiphas
person
index
beck
depress
scale
conjunct
cognit
test
may
help
differenti
emot
problem
structur
cognit
deficit
proper
treatment
anxieti
depress
may
lead
improv
cognit
function
recognit
area
degre
cognit
difficulti
patient
ms
may
help
care
patient
patient
may
abl
learn
way
work
around
problem
problem
job
may
relat
cognit
problem
way
alter
job
may
found
patient
may
becom
disabl
work
problem
test
also
may
help
famili
understand
need
help
patient
deal
problem
becom
difficult
handl
alon
cognit
rehabilit
techniqu
test
patient
ms
center
investig
need
evalu
efficaci
techniqu
care
assess
patient
abil
disabl
crucial
proper
manag
mani
patient
chronic
symptom
prevent
symptomat
therapi
often
effect
allevi
afflict
produc
ms
allow
patient
live
product
comfort
life
caus
ms
unknown
theori
revolv
around
idea
diseas
either
autoimmun
virusmedi
still
reason
question
patholog
featur
incit
event
much
research
focus
cell
potenti
mechan
cell
could
initi
ms
hla
associ
found
mani
popul
howev
hla
marker
neither
necessari
suffici
confer
diseas
suscept
factor
confer
diseas
suscept
sought
time
confirm
evid
viral
caus
ms
investig
situ
hybrid
pcr
technolog
conduct
attempt
identifi
viral
nucleic
acid
cn
perhap
techniqu
assist
unravel
pathogenesi
ms
intrigu
possibl
molecular
mimicri
may
respons
initi
gener
autoreact
lymphocyt
mechan
involv
exposur
viral
bacteri
antigen
gener
immunolog
respons
consist
reactiv
tcell
popul
cell
crossreact
myelin
peptid
potenti
demyelin
exist
theoret
mechan
known
caus
demyelin
rabbit
interest
investig
human
mbpreactiv
cell
demonstr
mbpspecif
tcell
clone
recogn
multipl
viral
polypeptid
present
dql
mhc
antigen
would
impli
ms
could
gener
exposur
one
number
antigen
stimuli
influenza
virus
herpesvirus
even
bacteri
antigen
select
activ
tcell
popul
enter
cn
could
recogn
myelin
epitop
initi
autoimmun
respons
would
persist
long
incit
infect
clear
recent
investig
mr
spectroscopi
demonstr
white
matter
outsid
ms
plaqu
may
find
may
signifi
fundament
abnorm
white
matter
whether
find
secondari
genet
biochem
autoimmun
viral
factor
remain
determin
despit
defici
understand
diseas
pathogenesi
therapi
ms
advanc
phase
iii
clinic
trial
copolym
demonstr
modest
definit
benefit
mechan
drug
favor
influenc
clinic
cours
ms
remain
elucid
recent
studi
chemotherapeut
agent
suggest
control
chronic
progress
diseas
may
real
possibl
futur
clinic
trial
attempt
defin
efficaci
paramet
therapi
anoth
question
remain
unansw
whether
use
multipledrug
therapi
might
benefici
treatment
ms
exampl
combin
therapi
copolym
may
produc
benefit
either
drug
alon
chronic
progress
diseas
use
solumedrol
combin
anoth
immunosuppress
azathioprin
methotrex
also
explor
remyelin
anoth
topic
interest
futur
research
research
conduct
use
ivig
remyelin
agent
addit
oligodendrocyt
transplant
experi
conduct
canin
mode
may
eventu
use
human
patient
research
involv
medic
improv
symptom
limit
live
mani
patient
ms
ongo
continu
studi
agent
may
improv
conduct
poorli
myelin
area
agent
may
reduc
doubl
vision
improv
strength
possibl
reduc
tremor
research
need
evalu
dm
januari
compound
may
improv
qualiti
life
mani
patient
ms
although
caus
ms
remain
mysteri
import
advanc
made
understand
treatment
ms
past
year
trend
continu
may
divers
effect
therapi
offer
patient
ms
year
come
